The Joint Commission, Pfizer Independent Grants for Learning & Change (IGLC) and Bristol-Myers Squibb Independent Medical Education (IME) are collaborating to provide grant opportunities that support an array of projects designed to accelerate the adoption of evidence-based innovations that improve patient care and safety. This collaboration is designed to utilize the Request for Proposal (RFP) process to identify, fund and oversee projects related to specific improvement objectives that align the mutual interests of patients, health care providers and the two collaborating organizations. It is funded by Pfizer IGLC and Bristol-Myers Squibb IME Alliance and administered by The Joint Commission.
Pfizer IGLC and Bristol-Myers Squibb IME provide independent grant support to organizations for healthcare quality improvement and learning & change initiatives. For more information visit the Pfizer website.
The Joint Commission Pfizer IGLC and Bristol-Myers Squibb IME select topics to underwrite and administer quality improvement projects that will accelerate the adoption of evidence-based innovations that improve the health of patients and the community.
For questions regarding The Joint Commission Pfizer IGLC and Bristol-Myers Squibb IME collaboration and/or projects, please contact/email Scott Williams.
See collaboration projects below: